Go to deals
Private Equity | Other Industries

Spice Private Equity Ltd. has had a fairness opinion conducted on a public tender offer by GP Investments

On 14 July 2022, GP Swiss Ltd., a subsidiary of GP Investments, published a public tender offer for all publicly held registered shares of Spice Private Equity Ltd. (Spice). The independent members of the Board of Directors of Spice have had a fairness opinion conducted on the financial adequacy of this public tender offer. The offer price for each Spice share was US$16.25 net in cash. Following a successful offer, GP Investment intends to delist the stock from the SIX Swiss Stock Exchange.

Spice is a Swiss firm focused on global private equity investments. At the end of May 2022, the company had four main direct investments in the US and Brazil, as well as a portfolio of older legacy fund of funds investments.

GP Investments is an investment company domiciled in Bermuda and listed on the Luxembourg Stock Exchange. GP Investments already owned a majority of Spice’s voting rights and share capital prior to the launch of the tender offer.

Oaklins’ team in Switzerland was mandated by the independent members of the Board of Directors of Spice to provide a fairness opinion in order to assess the financial adequacy of the public tender offer. The work included the valuation of each individual investment using the appropriate valuation methods, as well as the consideration of various case-specific circumstances.

The fairness opinion is publicly available and can be downloaded from the website of the Swiss Takeover Board.

Service
Corporate finance services
Parties
“Great teamwork, excellent service, timely delivery. We couldn’t have asked for more from Oaklins. The impeccable fairness opinion provided was critical for the successful outcome of the recent public tender offer by GP Swiss Ltd. for Spice Private Equity Ltd.’s shares.”

David Emery

Chairman of the Board of Directors, Spice Private Equity Ltd.

Talk to the deal team

Dr. Daniel  Spring

Dr. Daniel Spring

Partner
Bern, Switzerland
Oaklins Switzerland
Dr. Jürg  Stucker

Dr. Jürg Stucker

Partner
Zurich, Switzerland
Oaklins Switzerland
 Christoph  Walker

Christoph Walker

Senior Associate
Zurich, Switzerland
Oaklins Switzerland

Related deals

IJssel Technologie agrees to sell the company to Argos Wityu
Private Equity | Business Support Services

IJssel Technologie agrees to sell the company to Argos Wityu

The shareholders of IJssel Technologie have agreed to sell a majority stake in the company to Argos Wityu. By partnering with Argos Wityu, IJssel Technologie welcomes a strong new shareholder that will help strengthen the company’s market-leading position and together will further improve IJssel Technologie’s service offering to address the relevant macro-economic developments, including the trend toward sustainable and smart industries.

Learn more
Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital
Private Equity | Agriculture

Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital

The shareholders of Brookdale Treeland Nurseries have sold a controlling stake to Rouge River Capital.

Learn more
Bio2 has been acquired by Alliando Group
Private Equity | Consumer & Retail

Bio2 has been acquired by Alliando Group

The private shareholders of Bio2, a Portuguese petcare wholesaler, have sold the company to Alliando Group.

Learn more